The over-expression of c-erbB-2/ HER-2, a receptor tyrosine kinase, correlates with poor prognosis in patients with breast and ovarian cancer. In the human breast cancer cell line, MDA-MB-435, c-erbB-2 overexpression results in increased chemoinvasion and higher metastatic properties in nude mice. However, the mechanisms by which c-erbB-2 increases the malignant potential of cells remains unclear. We have determined that over-expression of c-erbB-2 in MDA-MB-435 cells, and in some additional breast cancer cell lines, is associated with graphic increases in mRNA and protein levels of the actin bundling protein fascin. Heightened fascin expression has been observed in other systems to result in greatly increased cell motility, and indeed, our work employing semi-automated time-lapse microscopy demonstrates that MDA-MB-435 cells over-expressing c-erbB-2 exhibit signi®cantly heightened cellular dynamics and locomotion, while visualization of bundled micro®laments within ®xed cells revealed enhanced formation of dendritic-like processes, microspikes and other dynamic actin based structures. To address the means by which c-erbB-2 over-expression might result in elevated fascin levels, we identi®ed multiple perfect match TCF and NF-kB consensus sites in fascin's promoter and ®rst intron, which appeared consistent with the greater endogenous transcriptional activities of TCF and NF-kB in c-erbB-2 over-expressing MDA-MB-435 cells. While such transcriptional modulation may occur in the context of the intact gene/chromatin, subsequent tests using reporter constructs did not support involvement of these signaling pathways. In conclusion, highly increased fascin levels were observed in MDA-MB-435 over-expressing c-erbB-2, likely contributing to these cells' altered actin dynamics, and increased cell motility and malignancy. Studies in progress aim to discern the means by which c-erbB-2 over-expression leads to transcriptional activation of the fascin gene.
Introduction
The c-erbB-2 oncogene (also known as HER-2 or neu) encodes a transmembrane glycoprotein of 185 kDa (p185), which belongs to the EGF-receptor family of growth factor receptor tyrosine kinases (Hung and Lau, 1999; Klapper et al., 2000) . C-erbB-2 is ampli®ed or over-expressed in 20 ± 30% of all breast and ovarian cancers and is clinically associated with poor prognosis in patients with these tumors. Mutational activation of the rat neu oncogene (V?G at amino acid 659) is sucient to induce a higher metastatic potential in mouse 3T3 ®broblasts (Yu and Hung, 1991) , and cerbB-2 over-expression enhances the intrinsic metastatic properties of human lung cancer cells (Yu et al., 1994) . In the human breast cancer cell line MDA-MB-435, stable transfection and over-expression of c-erbB-2 results in increased metastatic properties and chemoinvasion in nude mice (Tan et al., 1997) , while the transgenic expression of c-erbB-2 in mouse breast epithelium induces mammary tumors and metastases (Guy et al., 1992; Muller et al., 1988) .
On the molecular level, c-erbB-2 activation results in its auto-phosphorylation at speci®c tyrosine residues, and thereby the association of SH2 domain containing proteins (Reese and Slamon, 1997) . For example, direct interaction and phosphorylation by c-erbB-2 has been demonstrated for Shc and grb2, leading to activation of the ras/ MAPK (Segatto et al., 1993) , PLCg (Fazioli et al., 1991) , and Pl3-K pathways (Peles et al., 1992) . Such Pl3-K activation has been recently indicated to result in increased p21-activated kinase-1 (PAK-1) function, and thereby enhanced cell motility (Adam et al., 1998) . Conversely, independent work has demonstrated Pl3-K dependent cell aggregation in response to heregulin b1 (Tan et al., 1999) . While of unclear signi®cance, c-erbB-2 is further associated with the multifunctional protein b-catenin (Ochiai et al., 1994) , known to have roles in cadherin mediated cell ± cell adhesion and signaling within the Wnt pathway (Behrens, 1999) . Thus, despite progress upon c-erbB-2's role in cell signaling, the mechanisms by which c-erbB-2 increases the malignant potential of tumor cells appear complex.
In light of the central roles of cell adhesion, motility and invasion in tumor cell behavior, proteins promoting such functions are likely to be directly or indirectly responsive to c-erbB-2 signaling. Indeed, activation or over-expression of c-erbB-2 is correlated with increased cell motility and invasion in various systems, accom-panied by alterations in cell and cytoskeletal morphologies including the generation of cellular projections such as microspikes, membrane rues and microvilli (Adam et al., 1998; De Corte et al., 1994; Yu et al., 1994) .
MDA-MB-435 breast cancer cells over-expressing cerbB-2, and other breast cancer cell lines having low or high endogenous levels of c-erbB-2, were employed to assess eects upon the cell motility associated protein fascin and components of the cadherin adhesion complex. We previously reported that b-catenin, an integral component of the cadherin adhesion complex (McCrea et al., 1991) and of Wnt signal transduction (Behrens, 1999) , and further, a phosphorylation substrate of c-erbB-2 (Ochiai et al., 1994) , coimmunoprecipitates with fascin to a limited extent from certain cell lines and tissue extracts (Tao et al., 1996) . Here, we report fascin's greatly increased mRNA and protein levels in response to c-erbB-2 over-expression, and correlative increases in cell dynamics and motility as assessed using video and semi-automated time-lapse cell tracking systems. To identify signaling pathways driving fascin's increased expression, we examined the fascin gene promoter and ®rst intron, revealing a striking number of perfect match TCF and NF-kB consensus binding sites. Further, higher endogenous TCF/b-catenin and NFkB activities were assayed in c-erbB-2 over-expressing cells, consistent with fascin's increased expression. While subsequent testing of luciferase reporter constructs did not support the role of these pathways in fascin's dierential gene expression, such regulation may occur in the context of the native gene/chromatin and additional unknown modulators. In summary, we demonstrate the elevated expression of the actin bundling protein fascin in a number of c-erbB-2 overexpressing breast cancer cell lines, one of which was examined in detail (MDA-MB-435), and found to exhibit greatly enhanced cell dynamics and motility. Our work raises the issue that proteins modulating actin structures and dynamics, such as fascin, are likely to directly contribute to aggressive cell behaviors.
Results
Upregulation of fascin protein expression in c-erbB-2 over-expressing breast cancer cells, and increased tyrosine phosphorylation of b-catenin Western blot analysis of cell extracts adjusted for protein concentration showed a dramatic increase of fascin levels in c-erbB-2 over-expressing MDA-MB-435.eb1 and 435.eb2 cells when compared with parental (435) and vector-control transfected cells (neo1) (Figure 1a ). This result was con®rmed via anti-fascin immunoprecipitation and subsequent anti-fascin Western blotting, and by anti-fascin immunostaining, which evidenced an almost complete absence of fascin protein in parental and vector-control cells (data not shown). ECF quanti®cation of fascin protein expression demonstrated respective 7.4-and 11.0-fold increases in MDA-MB-435.eb1 and 435.eb2 cells over levels in 435.neo1 cells (Figure 1b) . In this assay, fascin levels of the 435 parental cells were indistinguishable from background. No dierences in total cellular Ecadherin, a-catenin, or b-catenin protein levels were observed among these cell lines, although b-catenin evidenced 1.4-fold greater tyrosine phosphorylation in cells over-expressing c-erbB-2 (Figure 2) . Thus, while the protein levels of cadherin-catenin adhesion components remained stable, graphic elevations of the actin bundling and motility associated protein fascin were revealed in c-erbB-2 over-expressing MDA-MB-435 cells.
Fascin transcription is increased in c-erbB-2 over-expressing breast cancer cells Fascin's heightened expression in c-erbB-2 over-expressing breast cancer cells could result from factors including increased transcriptional activity of the fascin gene and/ or decreased degradation of fascin protein.
We evaluated fascin gene transcription via northern detection of fascin mRNA (Figure 3) , and via luciferase reporter analysis of fascin's promoter and ®rst intron ( Figure 4 ). As shown by northern analysis, c-erbB-2 over-expressing 435.eb2 cells contained increased fascin mRNA levels relative to 435 parental cells, which displayed no detectable fascin mRNA signal ( Figure 3 ). As anticipated, fascin transcript levels were comparably low in 435 parental and 435.neo1, while comparably elevated in 435.eb1 and 435.eb2 cells (435.eb1 data not shown). Thus, fascin's greater mRNA transcript levels in c-erbB-2 over-expressing cells (Figure 3 ) is in accordance with its elevated protein levels (Figure 1 ).
Fascin promoter and intron analysis reveals multiple TCF and NF-kB consensus binding sites, while luciferase reporter analysis does not support their role in fascin gene expression To address possible mechanisms governing fascin's increased transcription in c-erbB-2 over-expressing MDA-MB-435 cells, we examined fascin's promoter and ®rst intron (GenBank accession # U03057). Given our earlier ®nding that small fractions of fascin and bcatenin exist in shared protein complexes (Tao et al., 1996) , it was intriguing that fascin's promoter and ®rst intron contained 24 perfect consensus TCF (LEF) sites (Figure 4a ). The HMG-box family member TCF (or LEF) associates with DNA, and upon activation of the Wnt pathway, binds nuclear-translocated b-catenin to promote the transcription of genes important to cancer progression and development (Behrens, 1999; Eastman and Grosschedl, 1999) .
Indeed, consistent with the possibility that TCF/ bcatenin may play a role in fascin's transcriptional activation, we determined that c-erbB-2 over-expressing cells had higher endogenous TCF/ b-catenin transcriptional activities, as evaluated using established luciferase based reporters (TOP/ FOP¯ash) (Korinek et al., 1997) (Figure 4c) . Similarly of interest, we identi®ed 22 perfect match NF-kB consensus sites within fascin's promoter and ®rst intron (Figure 4a) , and elevated endogenous NF-kB activity within c-erbB-2 over-expressing MDA-MB-435 cells (Figure 4b ). Finally, 13 hormone response consensus elements and four glucocorticoid consensus sites were resolved in fascin's promoter and ®rst intron.
Four luciferase based reporter constructs were produced to test fascin's transcriptional regulation via TCF/b-catenin, NF-kB and/or glucocorticoid ( Figure  4a ). Transient transfection of each of the two fascin promoter constructs indicated that they were robustly transcribed relative to vector controls, but dierences were not apparent when comparing either construct in c-erbB-2 over-expressing versus control MDA-MB-435 cells (data not shown). Likewise, transient expression of either of the two fascin intron constructs, did not reveal dierential reporter activities coinciding with the elevated fascin mRNA and protein levels observed in c-erbB-2 over-expressing cells (data not shown). Finally, co-transfection of established activators/suppressors of Wnt (TCF/b-catenin) or NF-kB pathways (p50/p65), or combinations of such activators/suppressors, did not signi®cantly alter the transcriptional activity of fascin promoter or intron reporter constructs, nor did not the incubation of cells with agents known to activate/ suppress these or the glucocorticoid pathways (data not shown) (see Materials and methods). Thus, sequence analysis of the fascin gene (Figure 4a ), and assay of heightened endogenous TCF/ b-catenin or NF-kB activities (Figure 4c ), suggested a .eb2= c-erbB-2 transfected/overexpressing cell lines) using polyclonal antibodies against b-catenin and fascin, and a monoclonal antibody (c-neu-Ab3) against c-erbB-2. Fascin levels were upregulated in c-erbB-2 overexpressing cell lines, whereas b-catenin remained unaected. ECF analysis of fascin levels in 435.eb1 and 435.eb2 cell lines showed 7.4-and 11.0-fold increases, respectively, over the 435.neo1 control expression Figure 2 Immunoprecipitation (IP) from HeLa, MDA-MB-435.neo1, 435.eb1 and 435.eb2 cell extract using polyclonal antib-catenin antibody (Ab) with subsequent Western blotting for phosphotyrosine residues (P-TYR) and b-catenin. b-catenin is more highly tyrosine phosphorylated in 435.eb1 and 435.eb2 cells than in 435.neo1 cells. IP of HeLa cells with rabbit IgG (IgG) served as a control Figure 3 Northern blot of 435 parental and 435.eb2 cells. The human fascin probe consisted of the 366 bp internal SacI fragment of the human fascin cDNA sequence. From each cell line 20, 10, or 5 mg of total RNA were resolved upon a 1% agarose/3% formaldehyde gel. Tenmg RNA of human testis served as blotting control (c), rat GAPDH cDNA was used as internal loading control. Whereas fascin mRNA was readily detected in 435.eb2 cells, 435 parental cells showed no fascinmRNA signal even after long ®lm exposure. The human fascin mRNA is approximately 2.7 kb, as expected (see human fascin cDNA Genbank #U03057). M denotes molecular weight marker (Gibco BRL) conceivable mechanism by which fascin expression becomes elevated in c-erbB-2 over-expressing cells. However, our luciferase-based reporter analysis of the fascin gene promoter and intron did not support such a model, leaving open possibilities including the requirement for additional unknown signals, and/or that fascin's transcriptional regulation (via TCF/bcatenin, NF-kB and/or glucocorticoid, etc.), is refractory to assessment within the context of arti®cial plasmid constructs.
Increased fascin levels coincide with c-erbB-2 over-expression in other breast cancer cell lines
Given that c-erbB-2 over-expression in MDA-MB-345 cells results in substantially increased fascin mRNA and protein levels, we examined other breast cancer cell lines for expression of c-erbB-2, fascin, E-cadherin and catenins ( Figure 5 and Table 1 ). Comparison of Western blot band intensities revealed that fascin was more highly expressed in cells harboring both c-erbB-2 and b-catenin. The only cell line evidencing high fascin levels in the absence of c-erbB-2 over-expression was HBL100 (Ganey, 1982) . This cell line may be exceptional as it underwent in vitro transformation upon integration of the MPMV retroviral and SV40 genomes, with gain of tumorigenicity in nude mice (see Discussion) (Caron de Fromentel et al., 1985; Dhaliwal et al., 1990; Kzhyshkowska et al., 1996) . Therefore, while fascin expression did not coincide with c-erbB-2 expression in all cell lines, a correlation did exist when evaluating the co-presence of c-erbB-2 and b-catenin.
b-catenin does not appear to associate with c-erbB-2 or with fascin in MDA-MB-435 cells
To assess if c-erbB-2 over-expression alters the limited but reported association of fascin with b-catenin (Tao et al., 1996) , we examined fascin and b-catenin immunoprecipitates. In contrast to results from A431 and HeLa cells, and from brain extracts (Tao et al., 1996) , we were unable to visualize the co-immunoprecipitation of fascin with b-catenin in parental or cerbB-2 over-expressing MDA-MB-435 cells (data not shown). Recent results additionally suggest that fascin's association with b-catenin is likely to be indirect (X Fang and PD McCrea, unpublished data) lessening the likelihood of b-catenin's relevance to fascin's cytoplasmic (versus gene) function. Likewise, since b-catenin has been reported to associate with c-erbB-2 (Ochiai et al., 1994; Shibata et al., 1996) , we assayed for the presence of this complex in parental or c-erbB-2 overexpressing MDA-MB-435 cells. However, in our hands (in which positive control co-immunoprecipitations were successful), even gently washed immunoprecipitates from parental or c-erbB-2 over-expressing MDA-MB-435 cells did not evidence an association of bcatenin with c-erbB-2 (data not shown). Thus, our present study does not support the involvement of either of these two previously reported complexes in the c-erbB-2 mediated over-expression of fascin. 
Increased microspikes and filopodia in c-erbB-2 over-expressing breast cancer cells
Since fascin is an actin-bundling protein present in stress ®bers, microspikes, and ®lopodia, we used phalloidin-¯uorescence microscopy to visualize the distribution of ®lamentous actin (F-actin) and potential changes in the actin cytoskeleton of MDA-MB-435 cells over-expressing c-erbB-2. Both cell line clones over-expressing c-erbB-2 (435.eb1 and 435.eb2), displayed a graphically increased extent of microspike and ®lopodia formation when compared with control (vector-transfected or parental) cells ( Figure 6 ). In contrast, the formation of stress ®bers was not signi®cantly enhanced. It is noteworthy that cells exhibiting high fascin levels evidenced a polarized distribution of cellular projections and microspikes characteristic of motile cells.
Greatly increased cell surface activity and dendritic processes in MDA-MB-435 cells over-expressing c-erbB-2
To assess cellular dynamics in response to c-erbB-2/ fascin over-expression, time-lapse experiments were undertaken in vitro over 24 h. In contrast to parental cells, both of the c-erbB-2 over-expressing cell line clones (435.eb1 and 435.eb2) displayed highly dynamic dendritic phenotypes characterized by the extension and retraction of long branched cellular protrusions. Interestingly, such dendritic cell morphologies have been associated with the presence of high fascin levels Figure 5 Western blot of cell extracts of dierent breast cancer cell lines 435.neo1, 435.eb2, 231, 453, 361; BT483, 474; SkBr3) , the human milk-derived cell line HBL100, and the epidermoid carcinoma cell line A431 (control) for b-catenin and fascin. In all cancer cell lines, fascin was upregulated only when b-catenin expression coincided with c-erbB-2 overexpression (denoted as: 7 no or low detectable expression,+intermediate,++strong protein expression). Except for the transfected cell line 435.eb2, c-erbB-2 levels represent endogenous protein in other cell systems Yamashiro et al., 1998 Visually, the dierences in cell shapes between these two cell lines are obvious. Likewise, using cell length as a marker for dendritic morphologies, a statistically signi®cant dierence between the two cell types was observed (P=0.0396). However, this dierence was not as apparent as expected since most cells underwent mitosis within the observation period, such that all cells condensed to the same extent in 435.eb1 cells versus 435.neo1 cells. Figure 9 plots the timedependent minimum, average and maximum cell lengths observed, and indicates that while minimal cell lengths are similar, maximal cell lengths are much greater for 435.eb1 cells. Figure 9 further shows that 435.eb1 and 435.neo1 cells had almost the same average and maximal lengths at the initiation of the experiment immediately following cell plating. After the initial plating trauma, an almost continuous increase in maximal and average lengths can be observed in both cell lines. Interestingly, in 435.eb1 but not in 435.neo1 cells, cell length (`dendritic phenotype') and cell motility was positively correlated (P=0.034 versus 0.642, data not shown). In summary, quantitative analysis of time-lapse experiments demonstrated that MDA-MB-435 cells over-expressing cerbB-2 (and consequently the actin-bundling protein fascin) display a statistically signi®cant increased in vitro motility and formation of cell processes, cell behaviors that require dynamic rearrangements of the actin cytoskeleton.
Discussion
Our results reveal a striking increased expression of the actin-bundling protein fascin in two independent MDA-MB-435 breast cancer cell lines stably transfected to over-express c-erbB-2. These lines were each previously characterized as more invasive in vitro and more metastatic in nude mice when compared to parental or vector-control transfected cells (Tan et al., 1997) . As assessed using standard immuno¯uorescence and video technology, we ®nd that c-erbB-2 overexpressing cells display graphic rearrangements in their actin cytoskeleton, and signi®cantly increased cell dynamics and in vitro motility. Given fascin's known role in bundling actin ®laments and in promoting cell motility (Adams et al., 1999; Yamashiro et al., 1998) , its dramatically increased expression in c-erbB-2 overexpressing MDA-MB-435 cells and in other c-erbB-2 expressing breast cancer cell lines is consistent with the observed phenotype of increased cell velocity and dendritic morphology.
Fascin possess two actin-binding domains within a single molecule, facilitating the tight packing of actin Figure 7 Sequences of time-lapse video microscopy of cell lines MDA-MB-435.neo1 (a ± c) and 435.eb1 (d ± f) obtained at 0, 12, and 24 h. Fascin/c-erbB-2 overexpressing 435.eb1 cells displayed a higher in vitro motility, and some showed the formation of long dendritic cell processes (arrowheads) (phase contrast, 106) Oncogene C-erbB-2 upregulates fascin in breast cancer cell lines A Grothey et al ®laments within dynamic subcellular structures such as microspikes, lamellipodia and ®lopodia Tilney et al., 1998) . In the mouse, fascin mRNA and protein exist at higher levels in brain, uterus, spleen and testis, and are most abundant in dendritic cells of the neural and immune systems. Human pathologies such as Hodgkin's disease display highly elevated fascin expression within lymphoma tissues (Reed-Stenberg cells), very likely resulting from the gene's response to viral inducers such as EBV (Pinkus et al., 1997) . Pronounced (200-fold) increases in fascin expression is further apparent in B-lymphocytes transformed with EBV, and in Burkitt tumor cell lines harboring MPMV, EBNAs and LMPs (Mosialos et al., 1994; Kzhyshkowska et al., 1996) . Given that MPMV is likewise harbored within breast HBL100 cells (Caron de Fromentel et al., 1985) , viral induction of the fascin gene may account for fascin's observed shows the mean overall cell length over 24 h and the standard deviation for both cell populations. 435.eb1 cells demonstrated a much higher maximum cell length which almost gradually increased in the course of the experiment, whereas the minimum cell length was identical in both cell lines (see text). Dierences in average cell length between the 435.neo1 and 435.eb1 cell lines were not as dramatic as those of average velocity (Figure 8 ), but were statistically signi®cant (b) elevation in HBL100 cells in the absence of detectable c-erbB-2 expression.
To assess possible mechanisms by which c-erbB-2 over-expression increases fascin expression within MDA-MB-435 cells, we tested agents that stimulate or inhibit signaling pathways known to be activated via c-erbB-2, such as the ras/MAP kinase, Pl3 kinase and PLCg cascades (Fazioli et al., 1991; Peles et al., 1992; Segatto et al., 1993) . Given our ®nding of 22 NF-kB, 24 TCF and four glucocorticoid consensus binding sites within fascin's gene promoter and ®rst intron, we additionally tested agonists of the NF-kB, Wnt (TCF/ b-catenin) and glucocorticoid pathways. While exposure to the NF-kB activator IL-1 increased endogenous fascin protein levels in MDA-MB-435 cells by approximately twofold over 48 h, additional agents acting upon distinct molecular pathways (see Materials and methods), failed to display signi®cant eects upon endogenous fascin levels or reporter constructs (data not shown). Similarly, transient co-transfection of NFkB and/or Wnt (TCF/b-catenin) activators/inhibitors had little impact upon constructs reporting the transcriptional activity of fascin's promoter or intron (data not shown).
However, the NF-kB and/or Wnt (TCF/b-catenin) pathways may none the less contribute to modulating fascin's in vivo expression. For example, robust increases in endogenous fascin mRNA/protein levels, or the activities of exogenous reporters, may require parallel activation of as yet uncharacterized signaling cascades, or the activation of known pathways in combinations that have not yet been discerned. As mentioned previously, EBV transformation results in greatly increased fascin expression (Mosialos et al., 1994) . Given that EBV is known to induce NF-kB mediated signaling activity (Eliopoulos and Young, 1998) , our observation of higher endogenous NF-kB activities in c-erbB-2 over-expressing MDA-MB-435 cells and the identi®cation of multiple perfect match NF-kB consensus sites within the fascin promoter and ®rst intron suggests a role for NF-kB in the c-erbB-2 mediated upregulation of fascin. Likewise, rat mammary epithelial cells exposed to glucocorticoids have been reported to evidence markedly reduced fascin mRNA and protein levels (Wong et al., 1999) , in keeping with known glucocorticoid-induced increases of the NF-kB antagonist IkB (Aljada et al., 1999) . Additional supportive evidence of a steroid hormone eect upon fascin expression includes our recent demonstration of fascin's preferential upregulation in hormone receptor negative breast cancers (Grothey et al., 2000) . Wnt (TCF/b-catenin) involvement likewise remains conceivable given our observations of the strikingly large number of TCF sites within fascin's promoter and ®rst intron, the correlative co-presence of b-catenin and c-erbB-2 in breast cancer cell lines, and c-erbB-2's reported (but not repeated in our hands) interaction with b-catenin (Ochiai et al., 1994; Shibata et al., 1996) . In all cases, further analysis of the fascin gene and of impinging signaling cascades will be required to clarify c-erbB-2 driven processes contributing to increased fascin levels, and thereby to more aggressive cellular behaviors.
Various proteins that modulate actin cytoskeletal dynamics have been associated with an increased malignant potential in tumor cells, for example, the small G-proteins Rac, Rho, and cdc42, and the guanine nucleotide exchange factor Tiam-1 (del Peso et al., 1997; Hordijk et al., 1997; Keely et al., 1997) . Increased cell motility and invasiveness require enhanced plasticity of the actin cytoskeleton, which is regulated via actin associated proteins (Mitchison and Cramer, 1996) . In addition to our work, fascin's importance in generating and/or maintaining dynamic cellular processes has been indicated following fascin's stable over-expression within normal kidney epithelial cells, causing the loss of cell ± cell junction integrity, the development of a ®broblastic phenotype and dramatically increased cellular dynamics and motility (Yamashiro et al., 1998) . Antisense studies conducted upon fetal rat hippocampal neurons correspondingly demonstrated that fascin depletion results in the loss of ®lopodia and well-spread growth cones .
In conclusion, our observation of signi®cantly elevated dynamics and cell motility in c-erbB-2 overexpressing MDA-MB-435 cells, and of increased formation of actin-dependent, dynamic structures such as ®lopodia and microspikes, suggests that the induction of fascin in response to c-erbB-2 may play a role in promoting more invasive and metastatic cell properties. Therefore, fascin may serve as a downstream cytoskeletal eector of a more aggressive cellular phenotype within c-erbB-2 over-expressing cells.
Materials and methods

Cell lines and culture
The MDA-MB-435 cell line, obtained from Dr Janet Price (UT MDACC), is an estrogen receptor-negative cell line with ®broblastic morphology isolated from the pleural eusion of a patient with breast cancer (Cailleau et al., 1974) . Cells were grown in DMEM/F12 (Life Technologies, Inc. [GIBCO BRL], Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (GIBCO). During the time-lapse experiments described below, cells were maintained in Leibowitz medium (GIBCO). The generation and characterization of stably c-erbB-2 transfected clones (435.eb1 and 435.eb2), as well as vector alone transfected control cells (435.neo1), was previously described (Tan et al., 1997) . The breast cancer cell lines MDA-MB-231, MDA-MB-453, MDA-MB-361, BT 483, BT 474, and SKBR3 were obtained from the American Tissue Culture Collection (Rockville, MD, USA) and maintained in DMEM supplemented with 10% fetal bovine serum. All cell lines were ascertained to be mycoplasmanegative by 4,6-diamidino-2-phenylindole (DAPI) staining.
Cell culture and transfections
The breast cancer cell line MDA-MB-435 and clones stably transfected with c-erbB-2 (MDA-MB-435-eb1 and -eb2) (Tan et al., 1997) , were routinely grown in RPMI 1640 supplemented with 0.1% MEM non-essential amino acids, 0.1% sodium pyruvate, 0.1% vitamins and 10% fetal calf serum in the presence of 7% CO 2 . Transfections were carried out using Fugene 6 (Boehringer Mannheim), and a total plasmid DNA load of 1 mg per well of six well cell culture dishes. Plasmids harboring cDNAs coding for the p65 and p50 subunits of NF-kB (pRSV-p65kB and pRSVp50kB) (Reddy et al., 2000) , and an NF-kB luciferase reporter construct driven by four IkB consensus sites placed upstream of a minimal SV40 promoter (pGL-kB) (Reddy et al., 2000) , were gifts from WS Liao (UT MDACC). A plasmid coding for a super-repressive form of 1kB (Van Antwerp et al., 1996) , was kindly provided by PE Chiao (UT MDACC). Plasmids harboring cDNAs coding for human Tcf-4 (phTcf-4), dominant negative TCF (poNhTcf-4), and a TCF/ Lef luciferase reporter construct (pTOP-FLASH/ pFOPFLASH), were gifts from Mien-Chie Hung (UT MDACC) originating from H Clevers (U Hospital, Utrecht) (Korinek et al., 1997) . Stabilized Xenopus b-catenin cDNA with a C-terminal myc tag (pXBC69) (Yost et al., 1996) , was kindly provided by D Kimelman (U Washington) and inserted using standard subcloning methods into the BamHI/ EcoRI polylinker restriction sites of pCDNA3.1 (Invitrogen) (generating pXb/ pCDNA3.1). b-Engrailed (pbEn/ pCDNA3.1+MT), a myc-tagged chimera of stabilized Xenopus b-catenin and the constitutive transcriptional repressor domain of Drosophila Engrailed was produced as described (Montross et al., 2000) . Cells were transfected at 60 ± 70% con¯uence (seeded 1 day prior), and harvested 2 days following transfection.
Antibodies
Anity-puri®ed anti-fascin rabbit polyclonal antibodies were raised against mouse fascin protein, expressed and puri®ed as a thioredoxin fusion protein. The thioredoxin domain was cleaved from fascin via enterokinase treatment (Invitrogen, San Diego, CA, USA) (Dickason et al., 1995) . Hybridoma supernatant of the mouse monoclonal anti-fascin antibody clone 55 k-2 (Mosialos et al., 1994) was a generous gift of Dako Corp. (Carpinteria, CA, USA). Anti-b-catenin rabbit polyclonal antibodies were raised and anity puri®ed as previously indicated (McCrea et al., 1993) . The c-neu-Ab3 mouse monoclonal antibody against c-erbB-2 was obtained from Oncogene Science, Inc. (Uniondale, NY, USA); mouse monoclonal antibodies against E-cadherin, a-catenin, and phosphotyrosine were purchased from Transduction Laboratories (Lexington, KY, USA).
Western blot
Cell line extraction for Western blotting analysis occurred in RIPA buer (1% NP-40; 0.1% sodium dodecyl sulfate [SDS] ; 0.5% desoxycholate [DOC] ; 150 mM NaCl; 50 mM Tris, pH 7.5) or in boiling 26SDS-sample buer (4% SDS; 10% glycerol; 2% b-mercaptoethanol; 250 mM Tris-HCl, pH 6.8; 0.006% bromophenol blue). Protein concentrations of lysates were measured using the Bio-Rad DC Protein Assay kit (Bio-Rad Laboratories, Hercules, CA, USA). Either 10 or 25 mg of total protein of each lysate were resolved upon 7% SDS ± PAGE gels and electrotransferred to nitrocellulose. Monoclonal or anity-puri®ed polyclonal primary antibodies were incubated with blots at 1 : 500 to 1 : 1000 dilution in minimal volumes of TBS-T buer (20 mM Tris-HCl, pH 7.6; 137 mM NaCl; 0.1% Tween 20) and 5% dry milk for 1 ± 2 h at room temperature or for 16 h at 48C. Anti-mouse or anti-rabbit goat-HRP-conjugated secondary antibodies (Bio-Rad) were incubated at 1 : 3000 dilution for 1 h at room temperature. Proteins of interest were detected by enhanced chemiluminescence (ECL) (Amersham Corp., Arlington Heights, IL, USA). Protein expression was quanti®ed by enhanced chemi¯uorescence (ECF) analysis, in which proteins were separated by SDS ± PAGE and electrotransferred onto PVDF membranes. Immunodetection was performed using the Vistra Fluorescence Western blotting kit (Amersham), with signal ampli®cation by detection of the secondary antibody with an anti-¯uorescein alkaline phosphatase conjugate followed by the¯uorescent substrate AttoPhos (Cano et al., 1992) . Image analysis of ECF scans (Storm 840, Molecular Dynamics, Inc., Sunnyvale, CA, USA) was performed with ImageQuaNT (Molecular Dynamics).
Immunoprecipitation
Cell line extracts were prepared in 0.75% NP-40 in calciumfree phosphate buered saline (PBS 7 ) (136 mM NaCl, 2.6 mM KCl, 8 mM Na 2 HPO 4 , and 1.4 mM KH 2 PO 4 ), supplemented with protease inhibitors (1 ng/ml pepstatin, 2 ng/ml TLCK, 2 ng/ml leupeptin, 4 ng/ml aprotinin, 10 ng/ ml antipain, 50 ng/ml benzamidine, 10 ng/ml STI, 100 ng/ml iodoacetamide, 0.4 mM phenylmethylsulfonyl¯uoride [PMSF], 5 mM EDTA). For assessing the phosphorylation status of b-catenin, phosphatase inhibitors were included in the lysis buer (50 mM NaFl, 10 mM sodium pyrophosphate, 1 mM NaMb, 2 mM vanadate). After debris removal via centrifugation (14 000 r.p.m. microfuge, 30 min), the resulting supernatants were subjected to a preclearing step with normal rabbit serum, followed by immunoprecipitation using anitypuri®ed anti-b-catenin, anti-fascin, or normal rabbit IgG (negative control). Immunoprecipitates were washed twice in lysis buer and once in PBS 7 before their reduction in 50 ± 100 ml of 26SDS-sample buer at 958C for 5 min.
Northern blot
Con¯uent monolayers of 435 and 435.eb2 cells were lysed and their RNA extracted using the Ultraspec RNA isolation reagent from Biotecx (Houston, TX, USA). For each cell line, 20, 10, and 5 mg of total RNA were resolved upon a 1% agarose gel with 3% formaldehyde. RNA of human testis, which is known to have high fascin levels, served as control. Transfer occurred in 106SSC using a Stratagene pressure blotter at 80 mmHg for about 90 min onto a GeneScreen Plus nylon membrane (NEN Life Science Products, Boston, MA, USA). After transfer, the transferred RNA was crosslinked to the membrane using an UV cross-linker (Stratagene, La Jolla, CA, USA). UV visualization of the gel revealed that almost all of the RNA had been evenly transferred to the membrane. Only a reduced amount of RNA larger than 7 ± 10 kb remained in the gel. The human fascin probe consisted of the 366 bp internal (coding region) SacI fragment of the human fascin cDNA sequence in Bluescript (SK-hfas, kindly provided by G Mosialos) (see GenBank accession # U03057; probe comprised of positions 865 ± 1231 of this sequence). The probe was labeled with 32 PdATP (Amersham) and the Strip-EZ random-priming cDNA labeling kit (Ambion Corp., Austin, TX, USA). Both prehybridization and hybridization were performed in ZIP-HYB solution (Ambion) with addition of 0.1 mg/ml ®nal concentration boiled, sheared salmon sperm DNA for blocking. Prehybridization was approximately at 658C within a rotating hybridization oven. Then 50 ml of labeled probe was mixed with 150 ml of 1 mg/ml sheared salmon sperm DNA and 50 ml 206SSC, boiled 5 min, heated at 688C for 30 min and ®nally added to the hybridization tube. Hybridization continued at 658C overnight. For the control blot, the membrane was stripped at 658C using Strip-EZ dCTPdegrading stripping solutions (Ambion), rinsed twice in 0.1% SDS, and put back into a pre-hybridization solution as described above. A standard 32 P-dATP labeled GADPH probe fragment (approximately 1 kB) was used as control.
Fascin promoter/intron reporter constructs
Two overlapping reporter constructs of the mouse fascin promoter (GenBank # U90355) were PCR ampli®ed using primer sequences harboring KpN1 restriction sites: up-stream primers mFgp1/F-KpnI, -3448 NT, 5'-GGGGTACCCAGCT-GGAGAGTGCTTGT-3' or mFgp2/F-KpnI, -1168, 5'-GGG-GTACCATGGGAAAGCCATGCCATC-3', opposing downstream primer mFgp/B-KpnI, 18 NT, 5'-GGGGTACCTTA-GCCCGCTGCAGTTCT-3'. Ampli®ed fragments were inserted into the KpN1 polylinker site of pGL-3 Basic (Promega), which lacks an endogenous promoter. Two nonoverlapping reporter constructs spanning fascin's ®rst intron were produced via PCR ampli®cation employing primers harboring BamHI restriction sites: upstream primer mFgI1/FBamHI, 893 NT, 5'-CGGGATCCAACGAGGGGAACGT-GTCC-3' opposing down-stream primer mFgI1/B-BamHI, 3632 NT, 5'-CGGGATCCTCACTCATTCTTAGCCAGC-3'; and upstream primer mFgI2/F-XhoI, 3633 NT, 5'-CCGG-CTCGAGCAGGTGAGGCTGGGCTT-3', opposing downstream primer mFgI2/B-XhoI, 6451 NT, 5'-CCGGCTCGAG-GAGAAGGTCTCACAGTGTA-3'. Intron fragments were inserted into the luciferase reporter vector pGL3-Promoter (Promega), which contains the SV40 basal promoter. Correct orientation of the fascin promoter and ®rst intron fragments were veri®ed by cDNA sequencing of inserts from 5' and 3' ends.
Gene transcription reporter assays
Cells cultured within six well dishes were grown to 60 ± 70% con¯uence and transiently co-transfected (FuGENE 6, Boehringer Mannheim, Indianapolis, IN, USA) with 0.2 mg of the selected luciferase based fascin reporter construct and 0.2 mg of pRL-TK (Promega Madison, WI, USA), which harbors cDNA encoding Renilla luciferase and is employed to control for transfection eciencies. As above indicated and referenced, further co-transfections utilized plasmids (0.2 mg) harboring cDNAs encoding either NF-kB (p65 and/or p50), IkB, hTcf-4, dnTCF, b-catenin or b-Engrailed (data not shown). Total transfected cDNA loads were uniformly made to 1 mg per cell culture well using plasmid lacking insert (pGL3, Promega). Negative control transfections likewise employed plasmid lacking insert (pGL Basic). Transcriptional activities were measured using the dualluciferase reporter assay system according to the manufacturer's instructions (Promega).
Immunofluorescence microscopy
For staining of the actin-cytoskeleton, the MDA-MB-435.neo1, 435.eb1, and 435.eb2 cells were grown for 18 h on glass coverslips to 50 ± 80% con¯uence, ®xed for 15 min at room temperature using 3.75% formaldehyde-PBS, and permeabilized with 0.1% Triton X-100 in PBS. Cells were blocked with 0.2% BSA and 5% normal donkey serum (Jackson ImmunoResearch Labs, Inc., West Grove, PA, USA), and thereafter incubated with rhodamine (TRITC)-conjugated phalloidin (1 : 200) (Molecular Probes, Inc., Eugene, OR, USA) for 1 h at 378C. For visualization of fascin, cells were ®xed and permeabilized in methanol:acetone 1 : 1 for 2 min at room temperature, rinsed with 16PBS and blocked with 3% BSA in PBS. Hybridoma supernatant of mouse anti-fascin antibody was added in 1 : 5 ± 1 : 10 dilutions for 4 h at room temperature followed by three washes with PBS/0.75% NP-40. The secondary rhodamine-conjugated goat anti-mouse antibody (1 : 20 ± 1 : 50) was incubated for 1 h at room temperature.
Video microscopy and digital image acquisition
The tumor cell cultures were visualized using an inverted microscope (Olympus, Melville, NY, Model IX 70) with a 46objective (0.13 NA), phase optics, and a black-andwhite charge-coupled device (CCD) camera (Panasonic, Secaucus, NJ, Model BP500). The composite video signal from the camera was fed to a 24-bit frame grabber (Scion Corp., Frederick, MD, USA) housed in a PowerTowerPro225 computer (Power Computing, Round Rock, TX, USA) for digitization at maximum data integrity. The frame grabber had a resolution of 6406480 pixels, corresponding to a 3.262.4 mm ®eld of view for the 4x objective. A high-resolution monitor allowed real-time visualization of the digitized images. The computer also controlled the microscope XYZ motorized stage (Ludl Electronic Products Ltd., Hawthorne, NY, USA); IPLab Spectrum software (Scanalytics Inc., Fairfax, VA, USA) orchestrated the entire acquisition process, providing complete automation. The microscope stage was enclosed within a temperature-controlled incubator (Olympus, Melville, NY, USA) which maintained the ambient temperature at 37.0+0.18C.
Digital time-lapse recording
In conventional time-lapse recording of extended experiments, a ®xed ®eld of view is continuously monitored and recorded on video tapes (i.e. analog system). The video tapes are then post-processed to obtain a sequence of digital images. This approach, however, has two limitations: video recording results in loss of image quality (as much as 60%), and one is limited to monitoring a single ®eld, resulting in the need to conduct many experiments to ascertain the behavior of a cell population. To overcome these limitations, we used digital time-lapse recording to continuously monitor tumor cell cultures over extended periods. At ®xed and userspeci®ed time intervals, the computer moved the motorized stage according to preprogrammed locations of monitored culture wells and triggered the acquisition of a series of digital images. Experiments were typically conducted for 24 h with 30 min acquisition intervals. Each gray scale 6406480 pixel image required 314 Kb of disk space so that the resulting 48 frame sequence took 15 Mb of disk space. Images were stored on 1 Gb Jaz drive cartridges (Iomega, Roy, UT, USA) for post-processing. Sequences of digitized images were converted to QuickTime movies within IPLab Spectrum software for visualization and analysis of cell migration.
Cell tracking
Time-lapse experiments recorded frame sequences captured over 24 h. To determine the spatial movement of individual cells, phase-contrast optical cell centroids were ®rst marked by crosshairs and recorded as x-y-coordinates relative to the upper left edge of the frame displayed in the software package IP Lab (Scanalytics). A standardized calibration of the optical system for recording and image analysis allowed measurement determination in metric values (mm). To avoid a selection bias, all vital cells visible in the initial frame were included in the assessment and tracked over 24 h. If a mitotic event occurred, one of the daughter cells was randomly selected for further tracking. In total, the analysis included 24 435.eb1 and 21 435.neo1 cells in sequences of 48 frames. Thus, 1152 and 1008 x-y-coordinates were respectively recorded for 435.eb1 and 435.neo1 cells. The data was transferred to an Excel spreadsheet (Microsoft Corp., Redmond, WA, USA) and StatView 5.0 (Abacus Software, Berkeley, CA, USA) for further calculations and statistical analysis. For each cell and frame, the distance D d traveled between time points t 0 and t 1 was calculated as Dd=((x 11 7x 10 ) 2 +(y 11 7y 10 ) 2 ) 2 . The velocity v 1 of a cell at a given time point was expressed as v 1 =D d/30 [mm/min]. In view of the apparent dendritic morphology of c-erbB-2 overexpressing cells, we sought to obtain quantitative information on dierences in cell shape between 435.eb1 and 435.neo1 cells. To this end, the shape of each cell was outlined graphically in all frames by drawing a straight line from one cell edge to the centroid and then another linked line from the centroid to the furthest opposite cell edge. The summed length of the two lines was employed as an indication of overall`cell length', i.e. a marker for the spatial extension of cellular projections. As the same cells were analysed for cell length and cell tracking, changes in cell length and motility could be correlated. The paired Student t and Spearman rang correlation tests were used for statistical analysis.
Assay of signaling pathways modulating endogenous fascin gene and protein expression
To identify signaling cascades that might modulate endogenous fascin gene transcription or protein expression, we exposed cells to selected pathway antagonists and/or agonists (data not shown). Exogenous agents included: (1) Ras pathway antagonist HFP (a-hydroxyfarnesyl-phosphoric acid) (Gibbs et al., 1993) , cells cultured at 1 mM for 0, 6, 12, 24, 36 and 48 h prior to cell lysis and Western blotting; (2) P13 kinase antagonist Ly-294002 (Vlahos et al., 1994) , cells cultured at 50 mM for 0, 6, 12, 24, 36 and 48 h prior to cell lysis and Western blotting; (3) Small G-protein and p21 ras antagonist perillic acid (Crowell et al., 1991) , cells cultured at 1 mM for 0, 6, 12, 24, 36 and 48 h prior to cell lysis and Western blotting; (4) Src family PTK antagonist Pp1/2 (Calbiochem, La Jolla, CA, USA), cells cultured at 500 nM for 2, 6, 12 and 24 h prior to cell lysis and Western blotting; (5) NF-kB agonists IL-1 and TNF-a (Roche, Indianapolis, IN, USA), cells cultured at 10 ng/ml for 0, 2, 6, 8, 16, 24 and 36 h prior to cell lysis and Western blotting; and (6) glucocorticoid agonist dexamethasone (Wong et al., 1999) , cells cultured at 1 mM for 48 h prior to cell lysis and Western blotting. Some of these antagonists/agonists were further tested with respect to their ability to inhibit/stimulate transcription of our exogenously introduced (transiently transfected) luciferase based fascin reporter constructs (data not shown).
